Viewing Study NCT01832506


Ignite Creation Date: 2025-12-26 @ 1:16 PM
Ignite Modification Date: 2026-03-08 @ 11:26 PM
Study NCT ID: NCT01832506
Status: COMPLETED
Last Update Posted: 2020-08-06
First Post: 2013-04-05
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Japanese Phase 1 Trial of c-Met Inhibitor MSC2156119J in Subjects With Solid Tumors
Sponsor: Merck KGaA, Darmstadt, Germany
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MSC2156119J View
None Solid Tumors View
None c-Met inhibitor View
None Japanese View
None Phase 1 View